Il Dong Pharmaceutical Co Ltd (249420) — Cash Flow Reinvestment Rate
Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow Reinvestment Rate of 0.65x as of September 2025, reinvesting ₩7.32 Billion (capex ₩5.97 Billion plus investments ₩-1.35 Billion) from operating cash flow of ₩11.28 Billion. Check 249420 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Il Dong Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Il Dong Pharmaceutical Co Ltd across 6 annual periods. Explore long-term investment intensity of Il Dong Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year capital reinvestment analysis for Il Dong Pharmaceutical Co Ltd. For live market cap and broader valuation context, see market cap of Il Dong Pharmaceutical Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.95x | ₩26.81 Billion | ₩28.29 Billion | ₩14.05 Billion | ▲ +10.6% |
| 2020 | 0.86x | ₩16.59 Billion | ₩19.37 Billion | ₩14.35 Billion | ▲ +138.1% |
| 2019 | 0.36x | ₩14.89 Billion | ₩41.37 Billion | ₩12.06 Billion | ▲ +42.4% |
| 2018 | 0.25x | ₩16.85 Billion | ₩66.65 Billion | ₩15.09 Billion | ▼ -32.8% |
| 2017 | 0.38x | ₩27.71 Billion | ₩73.72 Billion | ₩16.73 Billion | ▼ -38.3% |
| 2016 | 0.61x | ₩28.01 Billion | ₩45.98 Billion | ₩14.22 Billion | — |